Lawmakers are examining the spending practices of pharmacy benefit managers (PBMs) in state programs. There are reports that states could potentially save significant amounts by reforming the role of middlemen in the pharmaceutical supply chain. Regulations and lawsuits related to PBMs and drug pricing are being pursued in some states.